This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2012
Title: Claudia Penafuerte-Diaz: Innovator in Cancer Immunotherapy
Introduction
Claudia Penafuerte-Diaz is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of cancer immunotherapy through her innovative research and development of novel therapeutic approaches.
Latest Patents
Claudia holds a patent for "Interleukin-2/soluble TGF-beta type II receptor B conjugates and methods and uses thereof." This patent describes a conjugate protein that comprises an IL-2 and a soluble TGF-beta type II receptor type B. The invention focuses on its use in cancer immunotherapy, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Claudia has demonstrated exceptional expertise in her field. Her work has been instrumental in developing new strategies for cancer treatment, reflecting her dedication to improving patient outcomes.
Collaborations
Claudia collaborates with Jacques Galipeau, further enhancing her research efforts and contributing to the advancement of cancer therapies.
Conclusion
Claudia Penafuerte-Diaz is a trailblazer in the realm of cancer immunotherapy, with her innovative patent and collaborative efforts paving the way for future advancements in the field. Her work exemplifies the impact of dedicated inventors on healthcare and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile